439 related articles for article (PubMed ID: 24888982)
21. Targeting the EWS-ETS transcriptional program by BET bromodomain inhibition in Ewing sarcoma.
Hensel T; Giorgi C; Schmidt O; Calzada-Wack J; Neff F; Buch T; Niggli FK; Schäfer BW; Burdach S; Richter GH
Oncotarget; 2016 Jan; 7(2):1451-63. PubMed ID: 26623725
[TBL] [Abstract][Full Text] [Related]
22. Expression profiling of EWS/FLI identifies NKX2.2 as a critical target gene in Ewing's sarcoma.
Smith R; Owen LA; Trem DJ; Wong JS; Whangbo JS; Golub TR; Lessnick SL
Cancer Cell; 2006 May; 9(5):405-16. PubMed ID: 16697960
[TBL] [Abstract][Full Text] [Related]
23. Molecular diagnosis in Ewing family tumors: the Rizzoli experience--222 consecutive cases in four years.
Gamberi G; Cocchi S; Benini S; Magagnoli G; Morandi L; Kreshak J; Gambarotti M; Picci P; Zanella L; Alberghini M
J Mol Diagn; 2011 May; 13(3):313-24. PubMed ID: 21458383
[TBL] [Abstract][Full Text] [Related]
24. A method for accurate detection of translocation junctions in Ewing family of tumors.
Morishita T; Bolander ME; Zhang K; Tamai S; Mii Y; Sarkar G
Mol Biotechnol; 2001 Jun; 18(2):97-104. PubMed ID: 11471459
[TBL] [Abstract][Full Text] [Related]
25. Molecular diagnosis of Ewing tumors: improved detection of EWS-FLI-1 and EWS-ERG chimeric transcripts and rapid determination of exon combinations.
Meier VS; Kühne T; Jundt G; Gudat F
Diagn Mol Pathol; 1998 Feb; 7(1):29-35. PubMed ID: 9646032
[TBL] [Abstract][Full Text] [Related]
26. Efficient Recreation of t(11;22) EWSR1-FLI1
Torres-Ruiz R; Martinez-Lage M; Martin MC; Garcia A; Bueno C; Castaño J; Ramirez JC; Menendez P; Cigudosa JC; Rodriguez-Perales S
Stem Cell Reports; 2017 May; 8(5):1408-1420. PubMed ID: 28494941
[TBL] [Abstract][Full Text] [Related]
27. EWS-FLI-1 expression triggers a Ewing's sarcoma initiation program in primary human mesenchymal stem cells.
Riggi N; Suvà ML; Suvà D; Cironi L; Provero P; Tercier S; Joseph JM; Stehle JC; Baumer K; Kindler V; Stamenkovic I
Cancer Res; 2008 Apr; 68(7):2176-85. PubMed ID: 18381423
[TBL] [Abstract][Full Text] [Related]
28. CRISPR-Cas9-guided oncogenic chromosomal translocations with conditional fusion protein expression in human mesenchymal cells.
Vanoli F; Tomishima M; Feng W; Lamribet K; Babin L; Brunet E; Jasin M
Proc Natl Acad Sci U S A; 2017 Apr; 114(14):3696-3701. PubMed ID: 28325870
[TBL] [Abstract][Full Text] [Related]
29. The Promoter-Associated Noncoding RNA
Palombo R; Frisone P; Fidaleo M; Mercatelli N; Sette C; Paronetto MP
Cancer Res; 2019 Jul; 79(14):3570-3582. PubMed ID: 31072811
[TBL] [Abstract][Full Text] [Related]
30. The many faces of atypical Ewing's sarcoma. A true entity mimicking sarcomas, carcinomas and lymphomas.
Machado I; Noguera R; Mateos EA; Calabuig-Fariñas S; López FI; Martínez A; Navarro S; Llombart-Bosch A
Virchows Arch; 2011 Mar; 458(3):281-90. PubMed ID: 21181413
[TBL] [Abstract][Full Text] [Related]
31. [Ewing's tumours, genetic and cellular aspects].
Delattre O
Pathol Biol (Paris); 2008 Jul; 56(5):257-9. PubMed ID: 18485618
[TBL] [Abstract][Full Text] [Related]
32. Induction of Chromosomal Translocations with CRISPR-Cas9 and Other Nucleases: Understanding the Repair Mechanisms That Give Rise to Translocations.
Brunet E; Jasin M
Adv Exp Med Biol; 2018; 1044():15-25. PubMed ID: 29956288
[TBL] [Abstract][Full Text] [Related]
33. Inducible chromosomal translocation of AML1 and ETO genes through Cre/loxP-mediated recombination in the mouse.
Buchholz F; Refaeli Y; Trumpp A; Bishop JM
EMBO Rep; 2000 Aug; 1(2):133-9. PubMed ID: 11265752
[TBL] [Abstract][Full Text] [Related]
34. EWS/FLI-1 silencing and gene profiling of Ewing cells reveal downstream oncogenic pathways and a crucial role for repression of insulin-like growth factor binding protein 3.
Prieur A; Tirode F; Cohen P; Delattre O
Mol Cell Biol; 2004 Aug; 24(16):7275-83. PubMed ID: 15282325
[TBL] [Abstract][Full Text] [Related]
35. Small-molecule screen identifies modulators of EWS/FLI1 target gene expression and cell survival in Ewing's sarcoma.
Boro A; Prêtre K; Rechfeld F; Thalhammer V; Oesch S; Wachtel M; Schäfer BW; Niggli FK
Int J Cancer; 2012 Nov; 131(9):2153-64. PubMed ID: 22323082
[TBL] [Abstract][Full Text] [Related]
36. FOXO1 is a direct target of EWS-Fli1 oncogenic fusion protein in Ewing's sarcoma cells.
Yang L; Hu HM; Zielinska-Kwiatkowska A; Chansky HA
Biochem Biophys Res Commun; 2010 Nov; 402(1):129-34. PubMed ID: 20933505
[TBL] [Abstract][Full Text] [Related]
37. Tumor-specific retargeting of an oncogenic transcription factor chimera results in dysregulation of chromatin and transcription.
Patel M; Simon JM; Iglesia MD; Wu SB; McFadden AW; Lieb JD; Davis IJ
Genome Res; 2012 Feb; 22(2):259-70. PubMed ID: 22086061
[TBL] [Abstract][Full Text] [Related]
38. Synthetic siRNA targeting the breakpoint of EWS/Fli-1 inhibits growth of Ewing sarcoma xenografts in a mouse model.
Takigami I; Ohno T; Kitade Y; Hara A; Nagano A; Kawai G; Saitou M; Matsuhashi A; Yamada K; Shimizu K
Int J Cancer; 2011 Jan; 128(1):216-26. PubMed ID: 20648560
[TBL] [Abstract][Full Text] [Related]
39. Highly personalized detection of minimal Ewing sarcoma disease burden from plasma tumor DNA.
Hayashi M; Chu D; Meyer CF; Llosa NJ; McCarty G; Morris CD; Levin AS; Wolinsky JP; Albert CM; Steppan DA; Park BH; Loeb DM
Cancer; 2016 Oct; 122(19):3015-23. PubMed ID: 27351911
[TBL] [Abstract][Full Text] [Related]
40. Microsatellites are EWS/FLI response elements: genomic "junk" is EWS/FLI's treasure.
Gangwal K; Lessnick SL
Cell Cycle; 2008 Oct; 7(20):3127-32. PubMed ID: 18927503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
